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Abstract 
Background and Aim: The prevalence of type 2 diabetes mellitus (T2DM) is increasing globally. There is increasing 
evidence in the correlation between altered vitamin D levels, thyroid dysfunction, and T2DM. The goal of this study 
was to evaluate the association between serum 25-hydroxy vitamin D (25(OH) D), lipid profile, glucose and thyroid-
related parameters among patients with T2DM and non-diabetic individuals. 
Methods: This case-control study was conducted on 228 individuals (110 type two diabetics and 118 healthy 
controls). The serum concentration of 25(OH) D was determined by chemiluminescence assay. Photometric methods 
measured serum levels of fasting blood glucose (FBG), calcium, phosphorous, total Cholesterol (TC), 
triacylglyceride (TG), high-density lipoprotein (HDL). Low-density lipoprotein (LDL) and VLDL levels were 
estimated from the Friedewald equation (LDL-C=TC–HDL-C–(TG/5)). The Elisa kit measured serum T4 and TSH.  
Results: 80% of Patients with T2DM and 71% of healthy individuals were suffering from vitamin D insufficiency. A 
non-significant relationship between TG (P=0.36), HDL (P=0.33), VLDL (P=0.36), T4 (P=0.56) calcium (P=0.39) and 
phosphorus (P=0.41) levels were showed in control and diabetic groups.  The levels of FBG (P=0.000), TC (P=0.001), 
LDL (P=0.004), TSH (P=0.000) were significantly higher, and the levels of 25 (OH) D (P=0.001) was significantly 
lower in the T2DM group compared to the non-diabetic group.  
Conclusion: We revealed that the serum level of 25 (OH) D is lower in patients with T2DM, and the TSH level is 
significantly higher compared to the non-diabetic group. Thyroid dysfunction and a low level of 25 (OH) D are 
associated with a high risk of T2DM. 
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The global incidence of diabetes mellitus will be 
increased from 285 million people in 2010 to 439 
million individuals in 2030 (1). Type 2 diabetes 
mellitus (T2DM) accounts for about 90% of adult 
diabetes (2). T2DM is usually determined by a 
relative or absolute deficiency in insulin secretion 
and insulin resistance, which is associated with 
glucose and lipid metabolism abnormalities (2, 3). 
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This endocrine disorder resulting from the 
combination of multiple risk factors, including 
nutritional, genetic, environmental, and behavioral 
factors (4).    
Vitamin D is a multifunctional hormone and an 
essential nutritional factor for human health (5, 6). 
The significant well-known action of 25 (OH) D in 
bone metabolism and calcium homeostasis (7). 
However, accumulating evidence suggests that 
vitamin D and calcium are associated with 
numerous skeletal and non-skeletal disorders in the 
clinic (8). Several epidemiological reports have 
focused on the potential action of vitamin D in 
insulin secretion and glucose metabolism (9). The 
supplementation of vitamin D and calcium can 
improve glucose homeostasis and T2DM risk (10). 
The serum 25-hydroxyvitamin D [25(OH) D] level 
is accepted as an index of vitamin D status in the 
human body, which is inversely related to diabetes 
prevalence (11, 12). 
Also, several clinical research has shown that 
vitamin D deficiency is considered a risk factor in 
the pathogenesis of thyroid disorders among 
patients with T2DM (13, 14). Therefore, effective 
control of vitamin D status is a necessary manner to 
alleviate the incidence of thyroid diseases and 
T2DM (10, 15). Thyroid hormones have multiple 
functions in the regulation of glucose and lipid 
metabolism. The abnormalities of thyroid hormones 
are associated with insulin resistance and lipid 
metabolism disorders among patients with T2DM 
(16, 17).  
Therefore, this study aimed to investigate the serum 
levels of 25 (OH) D, thyroid-related parameters, 
lipid profiles, calcium, phosphorus, and blood 
glucose levels between patients with T2DM and 
healthy individuals in Doran Hospital of Shiraz.  
Methods 
Briefly, in this case-control study, 110 patients with 
T2DM based on clinical findings, whose diabetes 
was confirmed by a physician, were randomly 
selected from patients referring to Doran Hospital. 
Also, we included 118 healthy individuals 
randomly as the control group among the relatives 
of diabetic patients with no history of diabetes and 
confirmed by fasting blood glucose (FBG) test. The 
inclusion criteria included: the diagnosis of T2DM 
for at least three years prior, the use of blood 
glucose-lowering drugs, willingness to participate, 
and a complete written questionnaire. Exclusion 
criteria included: displeasure or inability to 
participate in the study, liver disorder, known renal 
diseases or creatinine > 2 mg/dL, malabsorption, 
infertility, oligomenorrhea, Pregnancy, lactation, 
use of drugs that may affect bone metabolism 
(Estrogen, Calcitonin, etc.), smoking, alcohol 
Abuse, inactivity for more than one week, the use 
of calcium and vitamin D supplementation and 
severe obesity (BMI > 40 kg/m²). After overnight 
fasting, 10 ml of fasting blood sample was taken 
and carried to the laboratory of Doran Hospital to 
determine 25-(OH) vitamin D level, lipid profile, 
FBG, calcium, phosphorous, T4, and TSH 
parameters. The serum concentration of FBG, 
calcium, phosphorous, total cholesterol (TC), 
triacylglyceride (TG), High-Density Lipoprotein 
(HDL) were measured by photometric methods 
using a commercial kit (Pars Azmoon kit, Tehran, 
Iran). LDL and VLDL levels were estimated from 
the Friedewald equation (LDL-C=TC–HDL-C–
(TG/5)). We also measured the serum levels of T4 
and TSH using the Elisa kit (Pishtazteb, Iran). 
Serum 25(OH) D was measured by 
chemiluminescence kits manufactured by DiaSorin 
Company (Italy) with a normal range of 30-
100 ng/mL. Vitamin D insufficiency and sufficiency 
were defined with serum 25(OH) D <30 ng/mL and 
25(OH)D ≥ 30 ng/mL, respectively (18). Statistical 
analyses were performed using SPSS software, 
version 16 (Chicago, USA). All results were 
expressed as mean ± standard deviation (SD). The 
student's t-test determined the differences between 
the mean of continuous variables among 
experimental groups. The p-value<0.05 was 
considered statistically significant.  
Results 
In our study, 128 individuals (39% men and 61% of 
women) were enrolled. 110 patients (mean age 
49.33) with T2DM and 118 healthy individuals 
(mean age 47.84) as a control group were included. 
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All data among two diabetic and non-diabetic 
groups are presented as mean ± SD. The mean age 
of individuals, 25(OH) D, calcium, phosphorous, 
T4, TSH, FBG, and lipid profile in both control and 
diabetic groups are shown in Table 1.  
As shown in Table 1, there was a statistically 
significant association between mean FBS 
(P=0.000), TC (p=0.001), LDL (P=0.004), 25(OH) 
D (p=0.001), and TSH (p=0.000). FBS, TC, LDL, 
and TSH levels were significantly higher in the 
diabetic group compared to the control group and 
25(OH) D was significantly lower in the diabetic 
group compared to the control group. There was not 
any statistically significant association between 
mean age (p=0.31), TG (p=0.36), HDL (P=0.33), 
VLDL (p=0.36), calcium (p=0.39) and phosphorus 
(p=0.41) levels in control and diabetic groups. Also, 
the results of Table 1 showed that there was no 
significant difference in the T4 level (p=0.56) 
between the two diabetic and non-diabetic groups. 
Given that the TSH level (p=0.000) in the diabetic 
group is significantly higher than in the control 
group, it seems that diabetic patients have a way to 
increase this level in the body but not to increase 
the level of the thyroid hormone. 
The mean level of 25-(OH) vitamin D in the 
diabetic group was 22.76 ng/mL, and in the control 
group was 27.18 ng/ml. There was a significant 
difference between the two diabetic and control 
groups (Table 1).  
 
Table 1. The mean values of biochemical parameters FBG, TG, LDL, HDL, VLDL, TC, T4, TSH, calcium, 
phosphorous, and VitD3 
Variable  groups N Mean Std. Deviation p-value 
Age (year) 
Control 118 47.8429 12.45843 
0.31 
Diabetes 110 49.3333 12.31540 
FBG (mg/dL) 
Control 118 86.2429 8.02951 
0.000 
Diabetes 110 154.32 35.53244 
TG (mg/dL) 
Control 118 134.39 64.12440 
0.36 
Diabetes 110 141.45 64.72751 
Cholesterol (mg/dL) 
Control 118 162.84 29.73253 
0.001 
Diabetes 110 174.57 28.90835 
HDL (mg/dL) 
Control 118 40.9000 6.47219 
0.33 
Diabetes 110 41.7826 8.57065 
LDL (mg/dL) 
Control 118 95.0571 27.31392 
0.004 
Diabetes 110 104.49 27.59358 
VLDL (mg/dL) 
Control 118 26.8786 12.82488 
0.36 
Diabetes 110 28.2899 12.94550 
TSH  (µIU/mL) 
Control 118 3.2950 2.02340 
0.000 
Diabetes 110 7.1043 3.16239 
T4 (µg/dL) 
Control 118 7.4791 1.77227 
0.56 
Diabetes 110 7.3493 1.98973 
VitD3 (ng/mL) 
Control 118 27.18 7.91 
0.001 
Diabetes 110 22.76 8.31 
Calcium (mg/dL) 
Control 118 8.67 0.54 
0.39 
Diabetes 110 8.61 0.53 
Phosphorous (mg/dL) 
Control 118 3.91 0.76 
0.41 
Diabetes 110 3.84 0.65 
All results were expressed as mean ± standard deviation (SD) and p <0.05 was considered statistically significant. 
Abbreviations: FBG, fasting blood glucose; HDL, high-density lipoproteins; LDL, low-density lipoproteins; VLDL, Very 
low-density lipoproteins; TSH, thyroid-stimulating hormone; TG, triglyceride; TC, total cholesterol. VitD3, Vitamin D3 
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75.44 172 Insufficient 
24.56 56 Sufficient 
0 0 Toxicity 
 
Vitamin D insufficiency and sufficiency were 
defined with serum 25(OH) D <30 ng/mL and 
25(OH) D ≥30 ng/mL, respectively. The prevalence 
rate of vitamin D of sufficient and insufficient 
categories in all individuals was 56 (24.56%) and 
172 (75.44), respectively.  
As shown in Table 3, the prevalence rate of 
vitamin D insufficiency and sufficiency in the 
diabetic group were 88 (80%) and 22 (20%), 
respectively. These numbers for the control group 
were 84 (71%) and 34 (29%), respectively.  
 
Table 3. The prevalence rate of vitamin D insufficiency in both diabetic and control groups 
(OH) Vit D levels 
Diabetic group Control group 
mean±Sd N mean±Sd N 
30 ng/mL >(OH) Vit.D 19.2273±4.20334 88 (80%) 23.0714±3.37883 84(71%) 
(OH) Vit.D≥ 30 ng/mL 36.9091±4.65735 22(20%) 37.3235±6.65022 34(29%) 
Total 22.7636±8.30877 110 (100%) 27.1780±7.91151 118(100%) 
The results were dysplayed as mean ± standard deviation (SD) and percents. P < 0.05 was set as statistically significant. 
 
Discussion 
We reported that the serum 25-(OH) D level in 
patients with T2DM was significantly lower than in 
the control group, but the serum levels of FBS, 
cholesterol, LDL, and TSH were significantly 
higher in the diabetic group compared to the control 
group. There is any significant association between 
TG, T4, HDL, VLDL, calcium, and phosphorous 
levels in the control group and patients with T2DM.   
Based on animal and human studies, altered 25 
(OH) D status and calcium levels were associated 
with glycemic status and type 2 diabetes risk (19). 
Laboratory studies provide evidence for an 
association between vitamin D status and insulin 
resistance and hyperglycemia. A study on 100 
patients with T2DM suggested that the treatment 
with vitamin D was significantly improved the 
serum insulin, FBS levels, and insulin resistance 
(10). So, Adequate amounts of vitamin D can be 
associated with a significant reduction in the risk of 
diabetes (19, 20). In the present study, we analyzed 
serum levels of 25(OH) D, calcium, phosphorus, 
FBG, TC, TG, LDL, and HDL in patients with 
T2DM compared to the health group. Compared to 
the control group, patients with T2DM had higher 
levels of TC, LDL, and FBG. There was not any 
statistically significant association between mean 
TG, HDL, and VLDL levels among the control and 
diabetic groups. The serum 25 (OH) D levels were 
found significantly lower in diabetic groups than 
non-diabetics. All individuals were divided into two 
categories on the base of their measured 25-(OH) 
vitamin D serum levels. 25(OH) D levels are 
classified as sufficient (> 30) and insufficiency 
(<30 ng/mL). Vitamin D insufficiency has the 
highest rate among both T2DM and control groups. 
Also, in this study, there was not any statistically 
significant association between serum calcium and 
phosphorus levels in non-diabetic and diabetic 
groups. This result agreed with the previous study 
reported by Marwa et al., who showed that the 
levels of calcium and phosphorus don't alter among 
patients with T2DM and vitamin D deficiency (21, 
22). A study has also reported a significant 
relationship between saliva calcium and phosphorus 
healthy and diabetic persons according to gender 
(23).   
Many studies reported that vitamin D deficiency is 
related to thyroid disorders among patients with 
T2DM (13, 24). An association between T2DM and 
hypothyroidism has been reported, and these 
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endocrine disorders are often co-existing (25). 
Interestingly, low levels of thyroid hormones may 
affect lipid and glucose metabolism. Higher thyroid 
hormone levels are significantly associated with the 
improvement of insulin secretion in pre-diabetic 
individuals (25). Several studies indicated that the 
serum TSH levels in T2DM individuals were higher 
than non-diabetic controls (26, 27).  
Our results showed that TSH levels were 
significantly higher in the diabetic group compared 
to the healthy group. We also evaluate the 
relationship between plasma. T4 levels were 
decreased, but no significant association between 
T4 levels in control and the diabetic group was 
observed. 
Conclusion 
In conclusion, the findings of the present research 
suggested that there is a significant relation between 
T2DM with 25(OH) D and TSH levels, but no 
significant association between T4 levels in the two 
groups was observed. Low serum levels of T4 
within the normal range in people with subclinical 
hypothyroidism may be associated with the 
prevalence of T2DM.  
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